Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Paris › NPI 1093764847
Physician

Brodsky, Kenneth

Brodsky, Kenneth was paid $201K by Medicaid between Jan 2020 and Sep 2020, across 5 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 55% of everything it billed.

33Billing provider infoBRODSKY, KENNETH
PARIS, KY 40361
33aNPI1093764847assigned 05/09/2006
28Total paid$201K
24GClaims3,673
24DCodes billed5
24AFirst – last monthJan 2020 – Sep 2020
Compared with peers

Next to other Family Medicine Physician providers in Kentucky

Rank by total paid#136 of 352
Median peer was paid$90K
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20203,673$201K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 55% 1,802 807 $110K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 44% 1,730 780 $89K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 17 13 $2K
81025 <1% 108 105 $909.66
36415 Collection of venous blood by venipuncture <1% 16 15 $45.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.